SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurogen (NRGN)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
523 35 0 NRGN
Emcee:  Terry McCormick Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
473I own some nrgn but I don't feel particularly 'up on it'. That is akeokalani'nui-6/25/2007
472Also worth noting is that they intend to partner NG-273 at the beginning of the tuck-6/25/2007
471Puzzling, since the PR clearly states that there was one drug-related SAE, but dtuck-6/25/2007
470Data seems good. But what was the SAE? And what's the edge over lunesta or arkrw-6/25/2007
469Neurogen Announces Positive Results for Proprietary Insomnia Drug in Two Chronicnigel bates-6/25/2007
468fwiw, what I care about is the obesity program. Though the cpd is in an early skeokalani'nui-6/22/2007
467>>Gotta look at the burn. The psychological overhang of that shelf createstuck-6/22/2007
466>>Neurogen Proprietary Insomnia Compound Data for Two Studies Presented attuck-6/22/2007
465>>Neurogen files $100 mln universal shelf By Gabriel Madway Last Update: 4tuck-5/29/2007
464Thanks; that might explain the relative strength of NRGN, recently. Cheers, Tutuck-3/5/2007
463GSK has updated their pipeline, and their TRPV1 molecule is no longer listed as tommysdad-3/5/2007
462I don't follow any of the pain co's to add Tuck. I like all the 3 leadindr.praveen-2/8/2007
461Any thoughts about Aplindore versus XP13512, which is hot stuff today? I haven&tuck-2/8/2007
460GSK is in PII: gsk.com 705498 under Neurosciences. They probably searched fortommysdad-1/24/2007
459Not really my area of expertise, but by "not ergot derived" I think thtommysdad-1/24/2007
458[From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potetuck-1/17/2007
457Company tells me that since A is not ergot derived, a heritage it shares with Mikeokalani'nui-1/11/2007
456Thank you t-dad.keokalani'nui-1/8/2007
455They report a pKi of 4.9 vs. rat cortical 5HT2 receptors. Note that this is notommysdad-1/8/2007
454<i>Can anyone look behind this abstract to evaluate how "low" iskeokalani'nui-1/3/2007
453Tuck: I hope Anesiva's DD regarding competition is not representative of itNeuroInvestment-1/1/2007
452Here's the most comprehensive list of VR1 players I've seen to date, frotuck-1/1/2007
451CIBC: Neurogen Initiating Coverage: Diverse CNS Pipeline With Multiple 2007 Cataidos-12/29/2006
450Most immediate VR1 threat: Glaxo Listening to most their recent general presentuck-12/27/2006
449APLINDORE (DAB-452) EXHIBITS HIGH AFFINITY DOPAMINE D2 RECEPTOR PARTIAL AGONIStuck-12/27/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News